2026 NPPES data Clinical Genetics (M.D.) Physician NPI 1578520250 MD
Verify on CMS →

DEBORAH BARBOUTH, MD

Clinical Genetics (M.D.) Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
49
Medicare Part D claims · Clinical Genetics (M.D.) Physician avg: 261
Generic prescribing
27%
generic claims · 73% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3101/100
▼ 2 pts below national avg 83.1 · [object Object]
Industry payments
$10.1K
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEBORAH BARBOUTH, MD reported a CMS MIPS final score of 81.3101/100 — below the 83.1 national average — and filed 49 Medicare Part D claims in 2023.

81.3101/100
MIPS score · -2 vs avg
49
Part D claims, 2023
27%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEBORAH BARBOUTH, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DEBORAH BARBOUTH, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEBORAH BARBOUTH, MD?

Near national average

NPI registry status

Active

Issued 04/27/2006

NPI 1578520250

Primary specialty

Clinical Genetics (M.D.) Physician

Niche

825 US NPIs in this specialty

Medicare Part D claims

49 81% vs specialty avg

2023 prescription claims

Specialty avg: 261

MIPS final score

81.3101/100 1.7898999999999887% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Clinical Genetics (M.D.) Physician compares to other specialties among Florida providers

Florida providers

Clinical Genetics (M.D.) Physician share within Florida

1. Clinical Genetics (M.D.) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Clinical Genetics (M.D.) Physician share within Florida

Medicare quality performance — MIPS

DEBORAH BARBOUTH, MD's 2023 MIPS final score plotted against the Clinical Genetics (M.D.) Physician national average

Near national average
MIPS Final Score
81.3101/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Clinical Genetics (M.D.) Physician) — 81.3101/100 vs national avg 83.1

0%100%National avg83%81.3%
MIPS final score (Clinical Genetics (M.D.) Physician) — 81.3101/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH BARBOUTH, MD appears in the CMS NPPES registry as a Clinical Genetics (M.D.) Physician provider holding MD credentials at 1601 NW 12 AVE, MIAMI, FL, 33101, with a listed phone of (305) 243-4029. NPI 1578520250 was issued on 04/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARBOUTH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 49 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 73% brand-name and 27% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3101/100 for the 2023 performance year (Quality 78.455, Cost 50.5984), compared with the national average of 83.1.

Clinical Genetics (M.D.) Physician is a narrow specialty nationwide, with 825 enrolled providers across 50 states and an average of 261 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1601 NW 12 AVE
MIAMI, FL 33101

Provider Details

NPI 1578520250
Specialty Clinical Genetics (M.D.) Physician
Credentials MD
Gender Female
NPI Issued 04/27/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.3101
Final Score
Avg: 83.1
78.455
Quality
50.5984
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where DEBORAH BARBOUTH, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF MIAMI
MIAMI, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH BARBOUTH, MD. Source: openpaymentsdata.cms.gov.

Total received

$10.1K

Largest payer

GENZYME CORPORATION

Most common payment type

Travel and Lodging

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to DEBORAH BARBOUTH, MD. To verify DEBORAH BARBOUTH, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

DEBORAH BARBOUTH, MD — brand share 73.0%
Specialty average (est.)

73% brand-name claims vs 27% generic, on 49 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

49
Total Claims
$1.5M
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
49
Total Day Supply
1,428
Brand vs Generic
73% brand / 27% generic
Brand Drug Cost
$1.4M
Generic Drug Cost
$156K

Patient Demographics

Average Patient Age
59.3 years
Avg HCC Risk Score
0.87

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Cerdelga
Eliglustat Tartrate
24
Sapropterin Dihydrochloride
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical Genetics (M.D.) Physician Overview

How DEBORAH BARBOUTH, MD fits within the Clinical Genetics (M.D.) Physician landscape nationally.

825
Clinical Genetics (M.D.) Physician Providers in US
50
States with Clinical Genetics (M.D.) Physician
261
Avg Claims per Provider

DEBORAH BARBOUTH, MD's 49 claims are below the specialty average of 261.

Nearby Clinical Genetics (M.D.) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BARBOUTH.

Compare Clinical Genetics (M.D.) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH BARBOUTH, MD's specialty?
DEBORAH BARBOUTH, MD specializes in Clinical Genetics (M.D.) Physician and practices in MIAMI, Florida. Credentials: MD.
How much does DEBORAH BARBOUTH, MD prescribe under Medicare Part D?
In 2023, DEBORAH BARBOUTH, MD wrote 49 Medicare Part D claims totaling $1.5M in drug costs for N/A beneficiaries.
What is DEBORAH BARBOUTH, MD's Medicare quality score?
DEBORAH BARBOUTH, MD has a CMS MIPS Final Score of 81.3101/100 (Quality: 78.455, Cost: 50.5984). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEBORAH BARBOUTH, MD located?
DEBORAH BARBOUTH, MD is located at 1601 NW 12 AVE, MIAMI, FL, 33101. Phone: (305) 243-4029.
What is DEBORAH BARBOUTH, MD's NPI number?
DEBORAH BARBOUTH, MD's National Provider Identifier (NPI) is 1578520250, issued on 04/27/2006.
Does DEBORAH BARBOUTH, MD prescribe more brand-name or generic drugs?
DEBORAH BARBOUTH, MD's prescribing is 73% brand-name and 27% generic drugs by claim count, with $1.4M in brand drug costs.
How many Clinical Genetics (M.D.) Physician providers are there in the US?
There are 825 Clinical Genetics (M.D.) Physician providers across 50 states in the US. The average Clinical Genetics (M.D.) Physician provider writes 261 Medicare Part D claims per year.
What drugs does DEBORAH BARBOUTH, MD prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH BARBOUTH, MD's most frequently prescribed drugs include Cerdelga, Sapropterin Dihydrochloride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH BARBOUTH, MD accept Medicare?
DEBORAH BARBOUTH, MD appears in CMS Medicare data with 49 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH BARBOUTH, MD's credentials?
DEBORAH BARBOUTH, MD's NPI is 1578520250 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology